ProQR Therapeutics NV (PRQR)
1.34
0.00 (0.00%)
USD |
NASDAQ |
Oct 28, 12:53
ProQR Therapeutics Market Cap : 189.10M for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 189.10M |
| October 26, 2026 | 174.99M |
| October 23, 2026 | 182.05M |
| October 22, 2026 | 187.69M |
| October 21, 2026 | 193.34M |
| October 20, 2026 | 194.75M |
| October 19, 2026 | 184.87M |
| October 16, 2026 | 184.87M |
| October 15, 2026 | 204.63M |
| October 14, 2026 | 207.45M |
| October 13, 2026 | 208.86M |
| October 12, 2026 | 228.62M |
| October 09, 2026 | 230.03M |
| October 08, 2026 | 221.56M |
| October 07, 2026 | 230.03M |
| October 06, 2026 | 232.85M |
| October 05, 2026 | 235.67M |
| October 02, 2026 | 230.73M |
| October 01, 2026 | 230.03M |
| September 30, 2026 | 234.26M |
| September 29, 2026 | 232.85M |
| September 28, 2026 | 232.85M |
| September 25, 2026 | 232.85M |
| September 24, 2026 | 241.32M |
| September 23, 2026 | 239.91M |
| Date | Value |
|---|---|
| September 22, 2026 | 268.13M |
| September 21, 2026 | 262.49M |
| September 18, 2026 | 258.25M |
| September 17, 2026 | 266.72M |
| September 16, 2026 | 262.49M |
| September 15, 2026 | 259.66M |
| September 14, 2026 | 262.49M |
| September 11, 2026 | 262.49M |
| September 10, 2026 | 273.78M |
| September 09, 2026 | 280.83M |
| September 08, 2026 | 289.30M |
| September 04, 2026 | 292.12M |
| September 03, 2026 | 294.94M |
| September 02, 2026 | 303.41M |
| September 01, 2026 | 299.18M |
| August 31, 2026 | 300.59M |
| August 28, 2026 | 323.17M |
| August 27, 2026 | 327.40M |
| August 26, 2026 | 331.64M |
| August 25, 2026 | 335.87M |
| August 24, 2026 | 342.93M |
| August 21, 2026 | 330.22M |
| August 20, 2026 | 320.35M |
| August 19, 2026 | 313.29M |
| August 18, 2026 | 303.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pharming Group NV | 863.49M |
| NewAmsterdam Pharma Co. NV | 2.412B |
| argenx SE | 54.86B |
| Mirum Pharmaceuticals, Inc. | 5.515B |
| ACADIA Pharmaceuticals, Inc. | 3.481B |
Market Cap Related Metrics
| PS Ratio | 6.636 |
| PEG Ratio | -0.6312 |
| Price to Book Value | 2.081 |
| Price | 1.34 |
| Earnings Yield | -34.61% |
| PEGY Ratio | -0.6312 |